Lu S, Wang J, Yu Y, Yu X, et al. Tislelizumab Plus Chemotherapy as First-line Treatment for Locally Advanced or Metastatic Nonsquamous Non-Small Cell Lung Cancer (RATIONALE 304): A Randomized Phase 3 Trial. J Thorac Oncol 2021 May 22. pii: S1556-0864(21)02176.
PMID: 34033975